
Company valuation, historical trends, and peer comparisons.
According to Immatics N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 742.25M. This represents a change of -7.62% compared to the average of 803.46M of the last 4 quarters.
The mean historical Enterprise Value of Immatics N.V. over the last ten years is 509.44M. The current 742.25M Enterprise Value has changed 45.70% with respect to the historical average. Over the past ten years (40 quarters), IMTX's Enterprise Value was at its highest in in the June 2024 quarter at 1.01B. The Enterprise Value was at its lowest in in the June 2020 quarter at -62277579.73.
Average
509.44M
Median
505.47M
Minimum
222.43M
Maximum
763.23M
Discovering the peaks and valleys of Immatics N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 178.94%
Maximum Annual Enterprise Value = 763.23M
Minimum Annual Increase = -53.97%
Minimum Annual Enterprise Value = 222.43M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 763.23M | 48.86% |
| 2024 | 512.72M | -9.13% |
| 2023 | 564.26M | 37.30% |
| 2022 | 410.95M | -33.76% |
| 2021 | 620.44M | 178.94% |
| 2020 | 222.43M | -53.97% |
| 2019 | 483.28M | -3.00% |
The current Enterprise Value of Immatics N.V. (IMTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
613.40M
5-year avg
574.32M
10-year avg
509.44M
Immatics N.V.’s Enterprise Value is less than Immunocore Holdings plc (1.50B), greater than Lyell Immunopharma, Inc. (232.03M), greater than Allogene Therapeutics, Inc. (413.49M), greater than Atara Biotherapeutics, Inc. (90.32M), greater than Precision BioSciences, Inc. (135.65M), less than Janux Therapeutics, Inc. (1.07B), less than BioNTech SE (10.17B), greater than TScan Therapeutics, Inc. (2.71M), less than Legend Biotech Corporation (3.55B), greater than Cellectis S.A. (128.41M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.50B | $1.55B | |
| 232.03M | $268.09M | |
| 413.49M | $381.77M | |
| 90.32M | $83.66M | |
| 135.65M | $193.62M | |
| 1.07B | $1.08B | |
| 10.17B | $22.02B | |
| 2.71M | $11.98M | |
| 3.55B | $3.94B | |
| 128.41M | $109.21M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immatics N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immatics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Immatics N.V.'s Enterprise Value?
What is the highest Enterprise Value for Immatics N.V. (IMTX)?
What is the 3-year average Enterprise Value for Immatics N.V. (IMTX)?
What is the 5-year average Enterprise Value for Immatics N.V. (IMTX)?
How does the current Enterprise Value for Immatics N.V. (IMTX) compare to its historical average?